Recent Research Analysts’ Ratings Updates for RadNet (RDNT)

Several brokerages have updated their recommendations and price targets on shares of RadNet (NASDAQ: RDNT) in the last few weeks:

• 12/18/2025 – RadNet had its “strong-buy” rating reaffirmed by analysts at Raymond James Financial, Inc..
• 12/17/2025 – RadNet was given a new $90.00 price target on by analysts at Truist Financial Corporation.
• 12/16/2025 – RadNet was upgraded by analysts at The Goldman Sachs Group, Inc. to a “buy” rating.
• 12/15/2025 – RadNet had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/8/2025 – RadNet had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/1/2025 – RadNet had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/1/2025 – RadNet had its price target raised by analysts at B. Riley from $71.00 to $87.00. They now have a “buy” rating on the stock.
• 11/25/2025 – RadNet had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/19/2025 – RadNet had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/14/2025 – RadNet had its “strong-buy” rating reaffirmed by analysts at Raymond James Financial, Inc.. They now have a $95.00 price target on the stock.
• 11/13/2025 – RadNet had its price target raised by analysts at Barclays PLC from $79.00 to $86.00. They now have an “overweight” rating on the stock.
• 11/12/2025 – RadNet was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating.
• 11/12/2025 – RadNet had its price target raised by analysts at Truist Financial Corporation from $81.00 to $90.00. They now have a “buy” rating on the stock.

Insiders Place Their Bets

In other news, CAO Mital Patel sold 25,000 shares of the stock in a transaction on Monday, November 17th. The shares were sold at an average price of $76.06, for a total value of $1,901,500.00. Following the sale, the chief accounting officer owned 205,138 shares of the company’s stock, valued at approximately $15,602,796.28. This represents a 10.86% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders have sold a total of 50,000 shares of company stock worth $3,902,254 in the last quarter. Insiders own 5.60% of the company’s stock.

RadNet, Inc is a leading independent provider of outpatient diagnostic imaging services in the United States. Through a nationwide network of fixed-site imaging centers and affiliated joint-venture locations, the company delivers a comprehensive suite of radiology services including MRI, CT, PET/CT, ultrasound, X-ray, mammography, bone densitometry, nuclear medicine and interventional radiology procedures. RadNet also offers teleradiology and imaging management solutions to physician practices, hospitals and healthcare systems.

Founded in 1981 and headquartered in Los Angeles, RadNet has expanded its footprint organically and through strategic acquisitions.